Bridgewater Advisors Inc. Takes Position in Cigna Group (NYSE:CI)

Bridgewater Advisors Inc. bought a new position in shares of Cigna Group (NYSE:CI - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,046 shares of the health services provider's stock, valued at approximately $353,000.

Several other large investors also recently made changes to their positions in the business. Putney Financial Group LLC acquired a new position in shares of Cigna Group during the fourth quarter valued at $36,000. Transce3nd LLC acquired a new position in shares of Cigna Group during the fourth quarter valued at $38,000. Wayfinding Financial LLC acquired a new position in shares of Cigna Group during the first quarter valued at $40,000. Ameriflex Group Inc. acquired a new position in shares of Cigna Group during the fourth quarter valued at $44,000. Finally, Heck Capital Advisors LLC acquired a new position in shares of Cigna Group during the fourth quarter valued at $53,000. Institutional investors own 86.99% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Wall Street Zen raised Cigna Group from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, April 8th. Cantor Fitzgerald increased their target price on Cigna Group from $350.00 to $365.00 and gave the company an "overweight" rating in a research note on Thursday, March 20th. Piper Sandler increased their target price on Cigna Group from $348.00 to $374.00 and gave the company an "overweight" rating in a research note on Monday, May 5th. Royal Bank Of Canada reissued an "outperform" rating and issued a $371.00 target price on shares of Cigna Group in a research note on Thursday, June 26th. Finally, Robert W. Baird cut their target price on Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 15th. Two research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat, Cigna Group has an average rating of "Buy" and an average target price of $380.39.

Cigna Group Stock Down 1.0%

CI stock traded down $3.01 during mid-day trading on Friday, reaching $295.27. The company had a trading volume of 2,071,563 shares, compared to its average volume of 1,817,079. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.72 and a quick ratio of 0.72. The stock has a 50 day simple moving average of $314.51 and a two-hundred day simple moving average of $311.06. The company has a market capitalization of $78.88 billion, a price-to-earnings ratio of 16.35, a PEG ratio of 0.91 and a beta of 0.44. Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share for the quarter, beating analysts' consensus estimates of $6.35 by $0.39. The firm had revenue of $65.45 billion during the quarter, compared to the consensus estimate of $60.39 billion. Cigna Group had a return on equity of 18.63% and a net margin of 1.97%. The business's revenue was up 14.4% compared to the same quarter last year. During the same period last year, the company earned $6.47 earnings per share. As a group, equities analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd were given a $1.51 dividend. The ex-dividend date of this dividend was Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.05%. Cigna Group's payout ratio is 33.44%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.